EV Biologics, Inc. (YECO)

Market Cap	1.46M
Revenue (ttm)	9.47M
Net Income (ttm)	-551.58K
Shares Out	10.23M
EPS (ttm)	-0.23
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55,300
Open	0.200
Previous Close	0.200
Day's Range	0.102 - 0.200
52-Week Range	0.260 - 1.950
Beta	-1.14
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About EV Biologics

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: YECO

Financial Performance

In 2017, EV Biologics's revenue was $9.47 million, a decrease of -0.34% compared to the previous year's $9.51 million. Losses were -$551,581, -92.58% less than in 2017.